FDA Corrects Withdrawal of Drug Approval Notices

Summary

The Food and Drug Administration (FDA) has corrected a notice that withdrew approval of 61 new drug applications, 8 abbreviated antibiotic applications, and 36 abbreviated new drug applications, including an error that affected Abbott Laboratories' Heparin Sodium in 5% Dextrose Injection in CR3 Flexible Container.